0171.KLSE PeterLabs Holdings Bhd

Healthcare Pharmaceuticals Kuala Lumpur Exchange
Add to portfolio Ask AI about 0171.KLSE
0.2400 MYR
Close of Oct 27, 2026
0.1950 0.2800
Market cap
MYR 66.1M
P/E
-
P/B
0.86x
ROE
0.2%
Dividend yield
1.67%
Fundamental score
2.1/5

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Dec 2025.

Is 0171.KLSE undervalued?

Graham number

The Graham number of PeterLabs Holdings Bhd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PeterLabs Holdings Bhd fundamental analysis

10 of 22 checks passed

ROE 0/2

Low return on equity (0.2%), below 10%.

ROA 0/1

Return on assets (0.2%) is below the industry median (5.5%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (64.9%) is above the 5-year average (-16.0% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (64.9%) is above the industry median (15.6%).

Revenue Growth 1/2

Revenue grew 9.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (0.0%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

No interest expense reported.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (0.9x) is above the industry median (0.9x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield cannot be calculated.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 48.2%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About PeterLabs Holdings Bhd

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements. The company also engages in the distribution…

Full company profile